215 / 260
(
`
cr)
Note 21 Contract liabilities
As at
March 31, 2019
As at
March 31, 2018
For sale of products
ǮȦǪǬ
-
8.46
-
Note 22 Revenue from operations
'ĿƙîijijƑĚijîƥĿūŠ ūlj ƑĚDŽĚŠƭĚ ljƑūŞ ČūŠƥƑîČƥƙ DžĿƥĺ ČƭƙƥūŞĚƑƙȠ
(
`
cr)
Particulars
2018-19
2017-18
Sale of goods | services
Life Science Chemicals
1,352.13
1,130.67
Domestic
586.65
507.91
/NJƎūƑƥ
ǭǪǬȦǭǫ
608.83
Other operating revenue
18.73
13.93
Performance and Other Chemicals
2,879.84
2,368.88
Domestic
1,611.38
1,322.93
/NJƎūƑƥ
1,233.22
1,016.72
Other operating revenue
ǩǫȦǨǪ
29.23
Others
33.01
56.38
ǪȡǨǬǪȦǯǮ
3,555.93
Inter-segment revenue
227.17
218.01
Total revenue
4,037.81
3,337.92
¤ĚDŽĚŠƭĚ ljƑūŞ ūƎĚƑîƥĿūŠƙ ƭƎ ƥū cƭŠĚ ǩǦȡ ǨǦǧǭ ĿŠČŕƭēĚƙ ĚNJČĿƙĚ ēƭƥNj ūlj
`
ǪǨȦǧǫ ČƑȡ DžĺĿČĺ Ŀƙ ēĿƙČūŠƥĿŠƭĚē ĚljljĚČƥĿDŽĚ cƭŕNj Ǧǧȡ ǨǦǧǭ
ƭƎūŠ ĿŞƎŕĚŞĚŠƥîƥĿūŠ ūlj Hūūēƙ îŠē ¬ĚƑDŽĿČĚƙ ¹îNJ ȳH¬¹ȴ ĿŠ TŠēĿîȦ TŠ DŽĿĚDž ūlj ƥĺĚ îljūƑĚƙîĿē ƑĚƙƥƑƭČƥƭƑĿŠij ūlj ĿŠēĿƑĚČƥ ƥîNJĚƙȡ ƑĚDŽĚŠƭĚ
from operations for the year ended March 31, 2019 is not comparable with the previous year.
Reconciliation of revenue recognised with contract price:
(
`
cr)
Particulars
2018-19
2017-18
Contract price
ǩȡǯǯǦȦǫǪ
3,318.98
ēŏƭƙƥŞĚŠƥƙ ljūƑȠ
Consideration payable to customers - discounts
1
(22.62)
(36.63)
ūŠƥƑîČƥ ƎƑĿČĚ îŕŕūČîƥĚē ƥū ƭŠƙîƥĿƙǛĚē ƎĚƑljūƑŞîŠČĚ ūċŕĿijîƥĿūŠ ljūƑ ƙîŕĚ ūlj
services (net)
2
ȳǧȦǪǩȴ
-
Revenue from contract with customers
3,966.49
3,282.35
1
ūŠƙĿēĚƑîƥĿūŠ ƎîNjîċŕĚ ƥū ČƭƙƥūŞĚƑƙ ŕĿŒĚ ēĿƙČūƭŠƥƙ îŠē ƎƑĿČĚ ƑĚēƭČƥĿūŠƙ ūljljĚƑĚē ƥū ČƭƙƥūŞĚƑƙ îƑĚ ĚƙƥĿŞîƥĚē ūŠ ƙƎĚČĿǛČ ĿēĚŠƥĿǛĚē
basis and reduced from the contract price when the Company recognises revenue from the transfer of the related goods or
services to the customer and the entity pays or promises to pay the consideration.
2
ÀŠƙîƥĿƙǛĚē ƎĚƑljūƑŞîŠČĚ ūċŕĿijîƥĿūŠ ljūƑ ƙîŕĚ ūlj ƙĚƑDŽĿČĚƙ ČūŞƎƑĿƙĚƙ ƑĚDŽĚŠƭĚ ljƑūŞ ĿŠƙƭƑîŠČĚ îŠē ljƑĚĿijĺƥ ƙĚƑDŽĿČĚƙ ljūƑ ĚNJƎūƑƥƙ ĿŠȹ
progress as at March 31, 2019 of
`
6.12 cr, net of revenue recognised for such services for similar contracts in-progress as at
March 31, 2018 for
`
ǪȦǬǯ ČƑȦ ¹ĺĚ ƑĚDŽĚŠƭĚ ljūƑ ĚNJƎūƑƥƙ ĿŠ ƎƑūijƑĚƙƙ îƙ îƥ qîƑČĺ ǩǧȡ ǨǦǧǯ DžĿŕŕ ċĚ ƑĚČūijŠĿƙĚē ĿŠ ǨǦǧǯȹǨǦ ƭƎūŠ
ČūŞƎŕĚƥĿūŠ ūlj ƥĺĚ ĚNJƎūƑƥƙȦ
Consolidated
|
Notes to the Financial Statements
213